The Science Review

What Does Nicotine Actually Do to Male Sexual Performance?

We reviewed the human research on nicotine, blood flow, and erectile response. One controlled trial produced a result that's worth understanding before your next pouch.

Reviewed By: Flow Research DeskAugust 2026 • 9 minute read

A claim like "Nicotine kills your d*ck" sounds like it belongs in a group chat, not a research summary.

But strip away the phrasing, and there's an actual scientific question underneath it.

Does nicotine, on its own, measurably affect the physiological process behind an erection?

That question has been studied. Not extensively, but directly. And the answer is more specific, and more interesting, than most people assume.

Here's what the research actually shows.

THE MECHANISM
NICOTINE
VASCULAR TONE
BLOOD FLOW
ERECTILE RESPONSE

Erectile function is largely a vascular event. Anything that affects blood vessel function is relevant to it.

STEP 01

Step 1: Understanding the Mechanism

Before reviewing the study, it helps to understand what an erection actually requires physiologically.

Sexual stimulation triggers signals that relax smooth muscle in penile tissue and allow blood vessels to dilate. Blood flows in, outflow becomes restricted, and pressure builds. That's the erection.

This is why erectile health and cardiovascular health are treated as connected in clinical research rather than separate topics. A 2024 systematic review and meta-analysis covering 57 studies and more than 7,000 participants identified significant differences across multiple markers of vascular health between men with erectile dysfunction and men without it.

In plain terms, vascular function and erectile function move together.

Which is exactly why nicotine, a substance known to act on the cardiovascular system, is worth examining specifically.

STEP 02

Step 2: The Study That Isolated Nicotine

Most available research on smoking and erectile dysfunction can't isolate nicotine specifically, because cigarette smoke contains thousands of compounds beyond nicotine.

That's what makes one particular trial worth paying attention to.

STUDY CARD 01HUMAN CLINICAL TRIAL
DESIGNRandomized, double-blind, placebo-controlled, crossover
POPULATIONHealthy nonsmoking men
INTERVENTIONNicotine vs. placebo prior to erotic stimulus
MEASUREMENTObjective physiological arousal response
RESULT23% reduction in physiological arousal with nicotine vs. placebo
EVIDENCE TYPEAcute, controlled exposure
Acute Effects of Nicotine on Physiological and Subjective Sexual Arousal in Nonsmoking Men. The Journal of Sexual Medicine. 1

Researchers at the University of Texas ran a randomized, double-blind, placebo-controlled crossover trial. Healthy young men who did not smoke were given either nicotine or a placebo, then shown erotic material while researchers measured physiological erectile response using objective instrumentation, not self-report.

The result: nicotine was associated with a 23 percent reduction in physiological sexual arousal compared with placebo.1

What makes this finding stand out isn't just the number. It's what happened alongside it.

The men's subjective ratings of how aroused they felt did not significantly change.

Meaning their bodies responded differently to nicotine, even though their perception of arousal stayed roughly the same.

23%

REDUCTION IN PHYSIOLOGICAL SEXUAL AROUSAL, NICOTINE VS. PLACEBO.1

RANDOMIZEDDOUBLE-BLINDPLACEBO-CONTROLLEDCROSSOVER
STEP 03

Step 3: What This Study Does Not Prove

One study involving 28 participants is not the same thing as a settled scientific conclusion. Here's what this particular trial does not establish.

It does not prove that every nicotine user will experience erectile dysfunction.

It does not tell us what happens with years of repeated nicotine pouch use specifically, since the study looked at a single acute exposure.

It does not separate nicotine from every other lifestyle factor that might independently affect sexual performance.

What it does establish is narrower and, honestly, more useful. In a controlled setting, isolated nicotine produced a measurable, objective reduction in physiological erectile response, independent of how aroused participants believed themselves to be.

That's a specific finding. It deserves a specific, unexaggerated read.

SUPPORTED BY THE RESEARCH

What the data shows

  • In a controlled setting, isolated nicotine produced a measurable, objective reduction in physiological erectile response.
  • The result was independent of how aroused participants believed themselves to be.
NOT ESTABLISHED BY THIS RESEARCH

What the data does not show

  • It does not prove that every nicotine user will experience erectile dysfunction.
  • It does not tell us what happens with years of repeated nicotine pouch use specifically.
  • It does not separate nicotine from every other lifestyle factor that might independently affect sexual performance.
STEP 04

Step 4: Separating Nicotine From Smoking

Here's a distinction that gets flattened in most online discussion of this topic, and it matters.

There is considerably more research connecting cigarette smoking to erectile dysfunction than there is connecting nicotine alone to erectile dysfunction. Cigarette smoke contains thousands of chemicals. Findings about smoking cannot be attributed entirely to nicotine.

That said, the smoking research is substantial.

A systematic review concluded that smoking is strongly associated with erectile dysfunction, pointing to endothelial impairment, reduced nitric oxide availability, and oxidative stress as proposed mechanisms. The same review found evidence suggesting that smoking cessation may benefit erectile function over time.

Separately, a meta-analysis involving more than 28,000 participants found that current smokers had significantly greater odds of erectile dysfunction compared with nonsmokers.

So the honest summary looks like this.

Smoking has a large, well-documented association with erectile dysfunction, though it can't be attributed to nicotine alone.

Isolated nicotine, tested on its own in a controlled human trial, still produced a measurable reduction in physiological erectile response.

Neither finding requires the other to be true for both to be worth taking seriously.

EXPOSURE
ASSOCIATION STRENGTH
CAVEAT
Cigarette Smoking
Strong
Includes thousands of compounds beyond nicotine.
Isolated Nicotine
Demonstrated in controlled trial
Acute exposure, single study, 28 participants.
STEP 05

Step 5: Why This Research Matters to Nicotine Pouch Users Specifically

Most of the existing research was conducted on cigarette smokers, not pouch users. That's worth acknowledging directly rather than glossing over.

But nicotine pouches deliver nicotine into the bloodstream through buccal absorption, meaning it passes directly through the tissue of the mouth and into systemic circulation without first passing through the digestive system. That's part of why pouches work quickly. It's also why the nicotine itself still reaches circulation fast enough to matter physiologically. The isolated nicotine trial referenced above didn't involve cigarettes, vaping, or tobacco at all. It tested nicotine itself.

Which means the mechanism being studied, nicotine's acute effect on physiological arousal, is directly relevant to anyone getting nicotine into their system regularly, regardless of format.

That includes pouch users.

So the research question isn't really "does smoking hurt sexual performance." It's narrower and more specific: does nicotine, independent of delivery method, have a measurable acute effect on erectile physiology.

Based on the available controlled trial, the answer appears to be yes.

SO WHAT DOES THIS MEAN FOR PRACTICE
NICOTINE

The variable being studied.

DELIVERY METHOD

Cigarette, vape, pouch — how it gets into your system.

SYSTEMIC NICOTINE EXPOSURE

Here's the part worth sitting with. Buccal absorption is a delivery mechanism, and not a nicotine-specific one. It's simply how anything placed against the inside of the cheek reaches the bloodstream, quickly, and without being broken down by digestion first. Nicotine happens to use that pathway. It isn't the only thing that can.

Which raises the same question we keep circling back to. If the pathway itself is neutral, and the ingredient is the actual variable, what happens if you keep the pathway and put something else through it.

If Nicotine Is the Variable, Removing It Is the Logical Next Question

Once you separate the ingredient from the format, a fairly obvious question follows.

If nicotine is the specific variable being studied, and pouches are simply a delivery method, what happens if you keep the delivery method and change the variable?

That's the exact question two entrepreneurs in Texas started asking after watching friends and family become increasingly dependent on nicotine pouches.

They weren't trying to build another stimulant product. They were trying to answer a formulation question: could a pouch still deliver cognitive and physical effects, focus, energy, blood flow support, and stamina, without nicotine or caffeine as the mechanism.

Working with formulation scientists, they built one.

The company is Flow.

Flow functional mushroom pouch product cans
PRODUCT FORMULATION

A POUCH FORMULATED AROUND WHAT'S REMOVED, NOT JUST WHAT'S ADDED.

0 Nicotine. 0 Caffeine.

What's Actually Inside Flow

Flow pouches replace nicotine with meaningfully dosed 100% organic fruiting body Lion's Mane, Cordyceps, and Reishi, combined with TeaCrine® and methylcobalamin vitamin B12.

Lion's Mane is included for focus and cognitive support. Cordyceps is included for energy, stamina, and blood flow support. Reishi is included for stress and general wellness support. TeaCrine® provides a naturally derived, non-caffeine energy mechanism designed to work alongside coffee or energy drinks rather than replace them entirely, without the jitters, crash, or dependency commonly associated with caffeine or nicotine. Methylcobalamin B12 supports energy metabolism.

Flow also keeps the same buccal absorption pathway that made pouches effective in the first place. The pouch sits against the inside of the cheek, and its ingredients are absorbed directly through the oral tissue into the bloodstream, bypassing the digestive system entirely. That's a meaningfully different route than a capsule or gummy, which has to survive digestion before anything reaches circulation. In practice, that means faster onset and better bioavailability for the ingredients themselves, not just for nicotine.

None of this is positioned as an erectile dysfunction treatment. It isn't marketed that way, and the research above doesn't support that framing either.

What Flow is positioned as is simpler and more defensible: a pouch built around ingredients other than the one shown, in controlled research, to acutely reduce physiological arousal response, delivered through the same fast absorption pathway that made pouches popular to begin with.

INGREDIENT KEYFUNCTIONAL CATEGORY
Lion's Mane
Cognitive Support
Cordyceps
Energy · Stamina · Blood Flow Support
Reishi
Stress Support · Wellness Support
TeaCrine®
Non-Caffeine Energy Support
Methylcobalamin Vitamin B12
Metabolic Support
DELIVERED VIA BUCCAL ABSORPTION. NO DIGESTION REQUIRED.
DIRECT
Cheek tissue to bloodstream

Ingredients are absorbed through oral tissue.

GI
TYPICAL CAPSULE, GUMMY, OR POWDER

Passes through the digestive system first.

The Data on Actual Use

Research on isolated nicotine explains the "why." Real-world usage data speaks to the "does it work as a substitute."

More than 103,000 people have tried Flow to date. In a self-reported 2026 post-purchase customer survey, 76 percent of respondents reported either quitting nicotine entirely or reducing their nicotine use by at least half.2

This is a self-reported survey result, not a controlled clinical trial, and it should be read as exactly that. It doesn't carry the same evidentiary weight as the randomized trial referenced earlier in this page. But directionally, it suggests the format-preservation approach is functioning the way it was designed to.

76%
REAL-WORLD USAGE DATAREPORTED EITHER QUITTING NICOTINE OR REDUCING THEIR NICOTINE USE BY AT LEAST HALFSELF-REPORTED · 2026 POST-PURCHASE CUSTOMER SURVEY

What We're Claiming, and What We're Not

Because this page is built around research, it's worth being explicit about where the evidence actually supports our claims and where it doesn't.

We're not claiming nicotine causes erectile dysfunction in all users. The available data doesn't support that.

We're not claiming Flow treats or reverses erectile dysfunction. It isn't formulated or marketed for that purpose.

We are saying that a controlled human trial found isolated nicotine acutely reduced physiological erectile response, independent of subjective arousal ratings. We are saying erectile function depends heavily on vascular health more broadly. And we are saying Flow was built specifically to let nicotine pouch users remove or reduce nicotine from their routine without also giving up the format itself, including the fast, buccal absorption delivery that made the format work in the first place.

That's a narrower claim than "nicotine kills your d*ck." It's also one we can actually stand behind.

THE MECHANISM, REVISITED
NICOTINE
VASCULAR TONE
BLOOD FLOW
ERECTILE RESPONSE
REMOVE NICOTINE → REMOVE THE VARIABLE
Flow Wintergreen functional mushroom pouches

Try It, Backed by a Guarantee

If you want to test the removal of that variable for yourself, Flow comes with a 60 day money back guarantee.

BUY 4 GET 4 FREE

FEEL FOR YOURSELF HOW FLOW WORKS

REFERENCES

1Acute Effects of Nicotine on Physiological and Subjective Sexual Arousal in Nonsmoking Men: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Sexual Medicine. 5(1):110 to 121. DOI: 10.1111/j.1743-6109.2007.00637.x

2In a self-reported 2026 Flow post-purchase customer survey.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.